Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, YungShin Global Holding Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
YungShin Global Holding Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, YungShin Global Holding Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where YungShin Global Holding Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YungShin Global Holding Co (TPE:3705) has a FCF Margin % of 9.91% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on YungShin Global Holding Co and its competitors. This is near median its historical median of 10.49. According to the industry distribution chart, YungShin Global Holding Co ranks #253 out of 959 companies in the Drug Manufacturers industry, placing it in the top 26.4%.
Is YungShin Global Holding Co's FCF Margin % too high?
YungShin Global Holding Co's current FCF Margin % of 9.91% is near median its 10-year median of 10.49. The Drug Manufacturers industry median FCF Margin % is 2.44. YungShin Global Holding Co's value of 9.91% is 306.1% above this industry median. Based on the distribution chart, YungShin Global Holding Co ranks #253 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, YungShin Global Holding Co has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does YungShin Global Holding Co's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, YungShin Global Holding Co ranks #253 out of 959 companies for FCF Margin %. This puts YungShin Global Holding Co in the upper half of its industry. The industry median FCF Margin % is 2.44. YungShin Global Holding Co's value of 9.91% is 306.1% above this benchmark. While the company's 10-year median is 10.49 vs. the industry median of 2.44, YungShin Global Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.44, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. YungShin Global Holding Co's current FCF Margin % of 9.91% is 306.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on YungShin Global Holding Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. YungShin Global Holding Co's current FCF Margin % is 9.91%, which is near median its own 10-year median of 10.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YungShin Global Holding Co stock overvalued right now?
Based on GuruFocus' analysis, YungShin Global Holding Co (TPE:3705) is currently considered Fairly Valued. The stock's GF Value™ is NT$53.89, compared to a current price of NT$55.80 — trading 3.5% above its estimated fair value. The current FCF Margin % is 9.91%, which is near median its 10-year median of 10.49 and 306.1% above the Drug Manufacturers industry median of 2.44. YungShin Global Holding Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For YungShin Global Holding Co (TPE:3705), the current FCF Margin % is 9.91% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is YungShin Global Holding Co (TPE:3705) Overvalued in 2026?
Based on GuruFocus' analysis, YungShin Global Holding Co stock appears to be overvalued.
The current stock price of NT$55.80 is trading 3.5% above its estimated GF Value™ of NT$53.89.
GuruFocus considers YungShin Global Holding Co to be Fairly Valued.
Key valuation signals for TPE:3705:
FCF Margin %: 9.91% (near median its 10-year median of 10.49)
GF Value™: NT$53.89 vs. price of NT$55.80 (3.5% above fair value)
Industry Position: 306.1% above the Drug Manufacturers median (#253 of 959)
No single metric tells the full story. See the TPE:3705 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
YungShin Global Holding Co Ltd invests, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics. The company derives revenue from the sale of Human drugs, Health food, Animal drugs, and Others. The company generates the majority of its revenue from Human drugs. Geographically, the company generates the revenue from Taiwan, the USA, Japan, and China, out of which the majority of its revenue is generated from Taiwan.
86GF Score
Get the complete analysis for TPE:3705
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3705 has been successfully added to your 
